Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
HEICO Class A
HEI.A
|
$914M |
| 2 |
UnitedHealth
UNH
|
$677M |
| 3 |
Ferguson
FERG
|
$652M |
| 4 |
Apple
AAPL
|
$642M |
| 5 |
Visa
V
|
$628M |
Top Sells
| 1 |
Vale
VALE
|
$940M |
| 2 |
Pinduoduo
PDD
|
$546M |
| 3 |
Meta Platforms (Facebook)
META
|
$418M |
| 4 |
Mid-America Apartment Communities
MAA
|
$369M |
| 5 |
NetEase
NTES
|
$330M |
Sector Composition
| 1 | Technology | 19.91% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.68% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 10.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3701
Dyne Therapeutics
DYN
$2.02B
| $112K | ﹤0.01% |
11,698
+292
| +3% | +$2.8K |
|
3702
Caribou Biosciences
CRBU
$174M
| $110K | ﹤0.01% |
+12,113
| New | +$110K |
|
3703
NexGen Energy
NXE
$4.46B
| $108K | ﹤0.01% |
19,167
-13,706
| -42% | -$77.2K |
|
3704
Rimini Street
RMNI
$416M
| $106K | ﹤0.01% |
18,170
-158
| -0.9% | -$922 |
|
3705
Farmmi
FAMI
$2.16M
| $103K | ﹤0.01% |
+285
| New | +$103K |
|
3706
Immunovant
IMVT
$2.99B
| $103K | ﹤0.01% |
18,700
+711
| +4% | +$3.92K |
|
3707
Standard BioTools
LAB
$497M
| $103K | ﹤0.01% |
28,600
-43,023
| -60% | -$155K |
|
|
CLVS
3708
DELISTED
Clovis Oncology, Inc.
CLVS
| $101K | ﹤0.01% |
49,947
+704
| +1% | +$1.42K |
|
|
URG
3709
Ur-Energy
URG
$536M
| $100K | ﹤0.01% |
62,451
+862
| +1% | +$1.38K |
|
|
KLRS
3710
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.4M
| $99K | ﹤0.01% |
636
+5
| +0.8% | +$778 |
|
|
GTH
3711
DELISTED
Genetron Holdings Limited ADS
GTH
| $99K | ﹤0.01% |
15,008
+6,947
| +86% | +$45.8K |
|
3712
Absci
ABSI
$368M
| $96K | ﹤0.01% |
+11,460
| New | +$96K |
|
3713
Precigen
PGEN
$1.3B
| $93K | ﹤0.01% |
44,573
+921
| +2% | +$1.92K |
|
3714
Cogent Biosciences
COGT
$1.82B
| $92K | ﹤0.01% |
12,258
+459
| +4% | +$3.45K |
|
3715
Rocket Lab Corporation Common Stock
RKLB
$22.1B
| $92K | ﹤0.01% |
11,527
-2,008
| -15% | -$16K |
|
|
SOS
3716
SOS Ltd
SOS
$10.9M
| $92K | ﹤0.01% |
228
+50
| +28% | +$20.2K |
|
3717
Verastem
VSTM
$663M
| $91K | ﹤0.01% |
5,399
+188
| +4% | +$3.17K |
|
3718
Sol-Gel Technologies
SLGL
$77.9M
| $89K | ﹤0.01% |
1,203
-322
| -21% | -$23.8K |
|
3719
Harvard Bioscience
HBIO
$21.3M
| $89K | ﹤0.01% |
14,406
-39,193
| -73% | -$242K |
|
3720
Curis
CRIS
$21M
| $88K | ﹤0.01% |
1,851
+7
| +0.4% | +$333 |
|
|
VLDR
3721
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $86K | ﹤0.01% |
33,555
-1,039
| -3% | -$2.66K |
|
3722
NeueHealth
NEUE
$60.3M
| $83K | ﹤0.01% |
538
+321
| +148% | +$49.5K |
|
|
LUNA
3723
DELISTED
Luna Innovations Incorporated
LUNA
| $83K | ﹤0.01% |
10,786
+137
| +1% | +$1.05K |
|
3724
Kartoon Studios
TOON
$38.5M
| $82K | ﹤0.01% |
8,082
+131
| +2% | +$1.33K |
|
3725
VistaGen Therapeutics
VTGN
$109M
| $81K | ﹤0.01% |
2,189
+24
| +1% | +$888 |
|